An abnormal gene expression of the β-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats

Hepatology

Volumn 48, Issue 6, 2008, Pages 1913-1923

  Ceolotto, Giulio ^a   Papparella, Italia ^a   Sticca, Antonietta ^a   Bova, Sergio ^a   Cavalli, Maurizio ^a   Cargnelli, Gabriella ^a   Semplicini, Andrea ^a   Gatta, Angelo ^a   Angeli, Paolo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; ISOPRENALINE; RGS2 PROTEIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARBON TETRACHLORIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PDE2A PROTEIN, RAT; RGS PROTEIN; RGS2 PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HEART LEFT VENTRICLE CONTRACTILITY; ISOLATED HEART; LIVER CIRRHOSIS; MALE; MICROARRAY ANALYSIS; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; WISTAR KYOTO RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEART CONTRACTION; HEART RATE; METABOLISM; PHYSIOLOGY;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; CARBON TETRACHLORIDE; CARDIOMYOPATHIES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; HEART RATE; ISOPROTERENOL; LIVER CIRRHOSIS; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 58149388301     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22533     Document Type: Article

References (35)

1. Moller S, Henriksen JH. Cardiovascular dysfunction in cirrhosis. Pathophysiologic evidence of a cirrhotic cardiomyopathy. Scand J Gastroenterol 201;36:786-794.
2. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. HEPATOLOGY 1996;24:451-459.
3. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology 2000; 118;937-944.
4. Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology 2001;121:1209-1218.
5. Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol 2005;146:315-323.
6. Gerbes AL, Remien J, Jungst D, Sauerbruch T, Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1986;1:1409-1411.
7. MacGilchrist AJ, Deighton NM, Hamilton CA, Reid JL. Binding studies of platelet α2- and lymphocyte β2-adrenoceptors in patients with cirrhosis. Br J Clin Pharmacol 1990;30:644-647.
8. Lee SS, Marty J, Mantz J, Samain E, Braillon A, Lebrec D. Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats. HEPATOLOGY 1990;12:481-485.
9. Ma Z, Meddings JB, Lee SS. Membrane physical properties determine cardiac β-adrenergic receptor function in cirrhotic rats. Am J Physiol 1994; 267:G87-G93.
10. Chung H, Hong DP, Kim HJ, Jang KS, Shin DM, Ahn JI, et al. Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride. Toxicol Appl Pharmacol 2005;208:242-254.
11. Tugues S, Morales-Ruiz M, Fernandez-Varo G, Ros J, Arteta D, Munoz-Luque J, et al. Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats. Gastroenterology 2005;129:1686-1695.
12. Angeli P, Jimenez W, Veggian R, Fasolato S, Volpin R, MacHenzie HS, et al. Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites. HEPATOLOGY 2000:31:304-310.
13. Bova S, Cargnelli G, D'Amato E, Forti S, Yang Q, Trevisi L, et al. Calcium-antagonist effect of norbormide, on isolated perfused heart and cardiac myocytes of guinea-pig. Br J Pharmacol 1997;120:14-19.
14. Xiang Y, Kobilka BK. Myocyte adrenoceptor signalling pathways. Science 2003;300:1530-1532.
15. Semplicini A, Lenzini L, Sartori M, Papparella I, Calò LA, Pagnin E, et al. Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens 2006;24:1115-1124.
16. Papparella I, Ceolotto G, Berto L, Cavalli M, Bova S, Cargnelli G, et al. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 2007;73:432-438.
17. Mani AR, Ippolito S, Ollosson R, Moore KP. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. HEPATOLOGY 2006;43:847-856.
18. Garcia-Estan J, Ortiz MC, Lee SS. Nitric oxide and renal and cardiac dysfunction in cirrhosis. Clin Sci (Lond) 2002;102:213-222.
19. Ma Z, Miyamoto A, Lee SS. Role of altered β-adrenergic signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996;110:1191-1198.
20. Janssen PM, Schillinger W, Donahue JK, Zeitz O, Emami S, Lehnart SE, et al. Intracellular beta-blockade: overexpression of Galpha(i2) depresses the beta-adrenergic response in intact myocardium. Cardiovasc Res 2002; 55:300-308.
21. Eschenhagen T, Mende U, Nose M, Schmitz W, Scholz H, Haverich A, et al. Increased messenger RNA level of the inhibitory G protein alpha subunit Gialpha-2 in human end-stage heart failure. Circ Res 1992;70:688-696.
22. Rochais F, Abi-Gerges A, Horner K, Lefebvre F, Cooper DMF, Conti M, et al. A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ Res 2006;28:1081-1088.
23. Mongillo M, Tocchetti CG, Terrin A, Lissandron V, Cheung YF, Dostmann WR, et al. Compartmentalized phosphodiesterase-2 activity blunt β-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ Res 2006;3:226-234.
24. Keravis T, Komas N, Lugnier C. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture:differential regulation in cobblestone and spindle phenotypes. J Vasc Res 2000;37:235-249.
25. Favot L, Keravis T, Lugnier C. Modulation of VEGF-induced endothelial cell cycle protein expression through cyclicAMP hydrolysis by PDE2 and PDE4. Thromb Haemost 2004;92:634-645.
26. Favot L, Keravis T, Holl V, Le Bec A, Lugnier C. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thromb Haemost 2003;90:334-343.
27. Geerts AM, De Vriese AS, Vanheule E, Van Vlierberghe H, Mortier S, Cheung KJ, et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 2006;26:889-898.
28. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J Hepatol 2005;43:98-103.
29. Wieland T, Lutz S, Chidiac P. Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system. Curr Opin Pharmacol 2007;7:201-207.
30. Roy AA, Baragli A, Bernstein LS, Hepler JR, Hèbert TE, Chidiac P. RGS2 interacts with Gs and adenylyl cyclise in living cells. Cell Signal 2006;18: 336-348.
31. Takeishi Y, Jalili T, Hoit BD, Kirkpatrick DL, Wagoner LE, Abraham WT, et al. Alterations in Ca2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res 2000;45:883-888.
32. Defer N, Best-Belpomme M, Hanoune J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol 2000; 279:F400-F416.
33. Ma Z, Zhang Y, Huet PM, Lee SS. Differential effects of jaundice and cirrhosis on beta-adrenoceptor signaling in three rat models of cirrhotic cardiomyopathy. J Hepatol 1999;30:485-491.
34. Rutschow S, Li J, Schultheiss HP, Pauschinger M. Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res 2006;69:646-656.
35. Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. HEPATOLOGY 2005;42:439-447.